ReviewInternational journal of molecular sciences2022

Camelid Single-Domain Antibodies: Promises and Challenges as Lifesaving Treatments.

Mehdi Arbabi-GhahroudiPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.